Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Fitness and its association with fatigue in persons with multiple sclerosis.
Example Based Lesion Segmentation.
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
The Added Value of Family Material in the Discovery of Multiple Sclerosis Genes.
CIDP presenting as recurrent severe back pain without weakness or sensory loss.
Multiple sclerosis: Immune reconstitution effective for MS.
Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?
Imag(in)ing multiple sclerosis: Time to take better pictures.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in rats.
Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model.
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »